Pfizer is Pleased to Announce the 2016 ASPIRE US Sickle Cell Disease Competitive Research Awards Program | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Pfizer is Pleased to Announce the 2016 ASPIRE US Sickle Cell Disease Competitive Research Awards Program


As competition increases for limited research funding, the ASPIRE Sickle Cell Disease program offers a new opportunity for researchers in the United States and underscores Pfizer’s commitment to supporting investigators with an interest in advancing innovation in Sickle Cell Disease.

Mission
To support basic science, translational and clinical research through a competitive grants program that advances medical knowledge in the pathogenesis and treatment of Sickle Cell Disease.
To support innovative pilot studies focused on improving patient outcomes in Sickle Cell Disease.
To support academic research as well as the career development of promising young and established scientists.

https://www.onescdvoice.com/wp-content/uploads/2017/02/ASPIRESCHead-1.jpg

expertly curated content related to this topic